Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
InMode Ltd. stock logo
INMD
InMode
$14.16
-1.1%
$14.64
$12.72
▼
$16.67
$823.12M2.03441,710 shs417,146 shs
SiBone stock logo
SIBN
SiBone
$19.68
-1.2%
$18.97
$11.48
▼
$21.89
$882.99M0.66584,405 shs1.17 million shs
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
$3.63
-6.9%
$4.78
$2.20
▼
$7.95
$240.14M0.47505,106 shs253,519 shs
Varex Imaging stock logo
VREX
Varex Imaging
$18.41
-0.3%
$18.48
$9.09
▼
$18.63
$777.59M0.97500,500 shs340,501 shs
7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
InMode Ltd. stock logo
INMD
InMode
-1.12%-0.35%-2.88%-8.47%-7.27%
SiBone stock logo
SIBN
SiBone
-1.16%+1.60%+6.15%+13.23%+29.30%
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
-6.92%-10.59%-26.37%-15.38%-20.04%
Varex Imaging stock logo
VREX
Varex Imaging
-0.32%-0.27%-0.32%+74.50%+57.35%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
InMode Ltd. stock logo
INMD
InMode
$14.16
-1.1%
$14.64
$12.72
▼
$16.67
$823.12M2.03441,710 shs417,146 shs
SiBone stock logo
SIBN
SiBone
$19.68
-1.2%
$18.97
$11.48
▼
$21.89
$882.99M0.66584,405 shs1.17 million shs
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
$3.63
-6.9%
$4.78
$2.20
▼
$7.95
$240.14M0.47505,106 shs253,519 shs
Varex Imaging stock logo
VREX
Varex Imaging
$18.41
-0.3%
$18.48
$9.09
▼
$18.63
$777.59M0.97500,500 shs340,501 shs
7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
InMode Ltd. stock logo
INMD
InMode
-1.12%-0.35%-2.88%-8.47%-7.27%
SiBone stock logo
SIBN
SiBone
-1.16%+1.60%+6.15%+13.23%+29.30%
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
-6.92%-10.59%-26.37%-15.38%-20.04%
Varex Imaging stock logo
VREX
Varex Imaging
-0.32%-0.27%-0.32%+74.50%+57.35%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
InMode Ltd. stock logo
INMD
InMode
2.00
Hold$16.0012.99% Upside
SiBone stock logo
SIBN
SiBone
2.71
Moderate Buy$24.5024.49% Upside
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
2.40
Hold$10.20180.99% Upside
Varex Imaging stock logo
VREX
Varex Imaging
2.00
Hold$16.88-8.34% Downside

Current Analyst Ratings Breakdown

Latest TLSI, SIBN, INMD, and VREX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/14/2026
SiBone stock logo
SIBN
SiBone
Boost Price TargetBuy$23.00 ➝ $25.00
10/8/2026
Varex Imaging stock logo
VREX
Varex Imaging
UpgradeHold (C-) ➝ Hold (C)
9/23/2026
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
Set Price Target$12.00
9/23/2026
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
Set Price Target$12.00
9/23/2026
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
Boost Price TargetBuy$11.00 ➝ $12.00
9/10/2026
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
UpgradeHold
9/9/2026
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
Initiated CoverageBuy$11.00
9/9/2026
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
Initiated CoverageBuy$11.00
8/26/2026
Varex Imaging stock logo
VREX
Varex Imaging
UpgradeSell (D+) ➝ Hold (C-)
8/20/2026
SiBone stock logo
SIBN
SiBone
UpgradeSell (E+) ➝ Sell (D-)
8/17/2026
Varex Imaging stock logo
VREX
Varex Imaging
DowngradeOutperform ➝ Market Perform
(Data available from 10/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
InMode Ltd. stock logo
INMD
InMode
$370.49M2.20$1.48 per share9.60$10.78 per share1.31
SiBone stock logo
SIBN
SiBone
$200.93M4.34N/AN/A$4.09 per share4.81
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
$45.15M4.95N/AN/A($0.68) per share-5.34
Varex Imaging stock logo
VREX
Varex Imaging
$844.60M0.92$3.87 per share4.76$11.73 per share1.57
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
InMode Ltd. stock logo
INMD
InMode
$93.83M$1.2311.46N/AN/A20.69%11.99%10.60%10/28/2026 (Estimated)
SiBone stock logo
SIBN
SiBone
-$18.90M-$0.34N/AN/AN/A-6.85%-8.23%-6.07%11/9/2026 (Estimated)
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
-$39.23M-$1.30N/AN/AN/A-62.59%N/A-64.47%11/12/2026 (Estimated)
Varex Imaging stock logo
VREX
Varex Imaging
-$70.30M$0.5217.1016.74N/A2.55%9.19%4.13%11/17/2026 (Estimated)

Latest TLSI, SIBN, INMD, and VREX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/12/2026Q3 2026
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
-$0.14N/AN/AN/A$14.02 millionN/A
11/11/2026Q3 2026
InMode Ltd. stock logo
INMD
InMode
$0.3220N/AN/AN/A$91.58 millionN/A
11/9/2026Q3 2026
SiBone stock logo
SIBN
SiBone
-$0.13N/AN/AN/A$55.27 millionN/A
8/10/2026Q3 2026
Varex Imaging stock logo
VREX
Varex Imaging
$0.2101$0.31+$0.0999$0.37$215.50 million$210.50 million
8/6/2026Q2 2026
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
-$0.1550-$0.16-$0.0050-$0.16$10.27 million$11.41 million
8/5/2026Q2 2026
InMode Ltd. stock logo
INMD
InMode
$0.3460$0.35+$0.0040$0.29$94.89 million$95.59 million
8/3/2026Q2 2026
SiBone stock logo
SIBN
SiBone
-$0.1495-$0.09+$0.0595-$0.09$55.34 million$56.01 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
InMode Ltd. stock logo
INMD
InMode
N/AN/AN/AN/AN/A
SiBone stock logo
SIBN
SiBone
N/AN/AN/AN/AN/A
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
N/AN/AN/AN/AN/A
Varex Imaging stock logo
VREX
Varex Imaging
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
InMode Ltd. stock logo
INMD
InMode
N/A
8.18
7.28
SiBone stock logo
SIBN
SiBone
0.20
9.15
7.55
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
5.05
5.35
4.97
Varex Imaging stock logo
VREX
Varex Imaging
0.64
3.38
1.53

Institutional Ownership

CompanyInstitutional Ownership
InMode Ltd. stock logo
INMD
InMode
68.04%
SiBone stock logo
SIBN
SiBone
98.11%
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
2.58%
Varex Imaging stock logo
VREX
Varex Imaging
N/A

Insider Ownership

CompanyInsider Ownership
InMode Ltd. stock logo
INMD
InMode
6.92%
SiBone stock logo
SIBN
SiBone
4.00%
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
16.30%
Varex Imaging stock logo
VREX
Varex Imaging
4.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
InMode Ltd. stock logo
INMD
InMode
66057.48 million53.50 millionOptionable
SiBone stock logo
SIBN
SiBone
37644.35 million42.58 millionOptionable
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
10261.58 million51.54 millionNot Optionable
Varex Imaging stock logo
VREX
Varex Imaging
2,40042.10 million40.16 millionOptionable

Recent News About These Companies

Teledyne: Varex Acquisition Strengthens The Buy Case
Teledyne to acquire Varex in $1.1 billion deal
Varex Imaging (VREX) Q3 2026

New MarketBeat Followers Over Time

Media Sentiment Over Time

InMode stock logo

InMode NASDAQ:INMD

$14.16 -0.16 (-1.12%)
Closing price 10/16/2026 04:00 PM Eastern
Extended Trading
$14.21 +0.05 (+0.35%)
As of 10/16/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

SiBone stock logo

SiBone NASDAQ:SIBN

$19.68 -0.23 (-1.16%)
Closing price 10/16/2026 04:00 PM Eastern
Extended Trading
$19.76 +0.08 (+0.41%)
As of 10/16/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

TriSalus Life Sciences stock logo

TriSalus Life Sciences NASDAQ:TLSI

$3.63 -0.27 (-6.92%)
Closing price 10/16/2026 04:00 PM Eastern
Extended Trading
$3.66 +0.02 (+0.69%)
As of 10/16/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

TriSalus Life Sciences, Inc., a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. The company offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial, for locally advanced pancreatic cancer. It also develops nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma with liver metastases, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and locally advanced pancreatic ductal adenocarcinoma. The company serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. TriSalus Life Sciences, Inc. was founded in 2009 and is headquartered in Westminster, Colorado.

Varex Imaging stock logo

Varex Imaging NASDAQ:VREX

$18.41 -0.06 (-0.32%)
Closing price 10/16/2026 04:00 PM Eastern
Extended Trading
$18.42 +0.02 (+0.08%)
As of 10/16/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products are used in a range of applications, including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses. The Industrial segment designs, develops, manufactures, sells, and services Linatron X-ray linear accelerators, X-ray tubes, digital detectors, high voltage connectors, and coolers for use in security and inspection applications, such as baggage screening at airports, cargo screening at ports and borders, and nondestructive testing, irradiation, and inspection in various applications. The company sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. It has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was incorporated in 2016 and is headquartered in Salt Lake City, Utah.